What Is Mod GRF 1-29? Uses, Benefits, Safety, FDA Status, and Evidence
Medical review note: This article is for educational purposes only and does not provide medical advice. Mod GRF 1-29 is not FDA-approved for human therapeutic use. Products sold online as Mod GRF 1-29, Modified GRF 1-29, tetrasubstituted GRF 1-29, CJC-1295 without DAC, or “research use only” Mod GRF 1-29 may carry serious safety, quality, legal, and anti-doping risks.
Quick answer
Mod GRF 1-29 is a modified analog of growth hormone-releasing hormone, also called GHRH. It is based on the shortest fully active GHRH fragment, GRF 1-29, but includes amino-acid substitutions intended to improve stability and resistance to enzymatic breakdown. Mod GRF 1-29 is often described as CJC-1295 without DAC, meaning it lacks the drug-affinity-complex modification that makes CJC-1295 DAC longer acting. It stimulates the pituitary gland to release growth hormone through the GHRH receptor. Human and preclinical research support the idea that GHRH analogs can increase growth hormone release, but Mod GRF 1-29 is not FDA-approved, lacks strong clinical-outcome evidence for anti-aging, fat loss, muscle growth, sleep, or recovery claims, and is prohibited in sport.
Key facts about Mod GRF 1-29
| Question | Answer |
|---|---|
| What is Mod GRF 1-29? | A modified 29-amino-acid growth hormone-releasing hormone analog. |
| Other names | Modified GRF 1-29, tetrasubstituted GRF 1-29, CJC-1295 without DAC, CJC-1295 no DAC. |
| Peptide class | GHRH analog / growth hormone-releasing factor analog. |
| Main mechanism | Activates the GHRH receptor on pituitary somatotroph cells to stimulate growth hormone release. |
| FDA-approved? | No. Mod GRF 1-29 is not an FDA-approved drug. |
| Related peptide | Sermorelin is GRF 1-29, the unmodified shortest active GHRH fragment. |
| Difference from CJC-1295 DAC | CJC-1295 DAC includes a drug-affinity-complex modification designed for much longer activity. Mod GRF 1-29 does not include DAC. |
| Main studied uses | Growth hormone stimulation, GHRH analog research, endocrine research, and peptide pharmacology. |
| Human evidence level | Limited human evidence for GH stimulation by related GHRH analogs; weak evidence for anti-aging, fat-loss, muscle-building, sleep, and recovery claims. |
| Animal/lab evidence level | Moderate mechanistic and preclinical evidence for GHRH receptor activation and GH release. |
| Common online claims | “Increases HGH,” “anti-aging,” “fat loss,” “muscle growth,” “recovery,” “better sleep,” “CJC without DAC,” “body recomposition.” |
| Sports status | Prohibited by WADA as a growth hormone-releasing factor or GHRH analog. |
| Main safety concern | Hormone-axis manipulation, limited long-term human safety data, product-quality risk, unknown dosing, and anti-doping prohibition. |
What is Mod GRF 1-29?
Mod GRF 1-29 is a synthetic analog of growth hormone-releasing hormone. GHRH is the hypothalamic hormone that tells the pituitary gland to release growth hormone.
The natural GHRH peptide is longer, but the first 29 amino acids are the shortest fragment that retains full growth hormone-releasing activity. That fragment is called GRF 1-29 and is also known as sermorelin.
Mod GRF 1-29 is a modified version of that 29-amino-acid fragment. It is commonly called tetrasubstituted GRF 1-29 because four amino acid positions are modified to improve stability.
The FDA’s PCAC material on CJC-1295 states that there have been modifications to GHRH over time, including CJC-1295 synthesized without DAC, which the FDA document identifies as CJC-1295 free base. This is the category often discussed online as CJC-1295 without DAC or Mod GRF 1-29.
The key distinction:
Mod GRF 1-29 is a modified GHRH analog. It is not the same as sermorelin, not the same as CJC-1295 DAC, and not an FDA-approved anti-aging or growth hormone therapy.
How does Mod GRF 1-29 work?
Mod GRF 1-29 works through the GHRH receptor.
GHRH normally binds to receptors on pituitary somatotroph cells. This stimulates growth hormone release. Growth hormone can then influence IGF-1 production, metabolism, body composition, tissue repair pathways, and many other biological systems.
In plain English:
Mod GRF 1-29 tells the pituitary gland to release growth hormone by mimicking the active part of GHRH.
This is different from growth hormone secretagogues such as GHRP-2, GHRP-6, ipamorelin, and hexarelin.
| Peptide type | Main receptor | Example |
|---|---|---|
| GHRH analog | GHRH receptor | Sermorelin, CJC-1295, Mod GRF 1-29 |
| GH secretagogue / GHRP | Ghrelin / GHSR receptor | GHRP-2, GHRP-6, ipamorelin, hexarelin |
| Recombinant GH | Supplies GH directly | Somatropin |
The practical interpretation:
Mod GRF 1-29 is upstream of growth hormone. It stimulates release of endogenous GH rather than supplying GH directly.
But mechanism is not proof.
A GH-stimulation mechanism does not prove that Mod GRF 1-29 reverses aging, builds muscle, burns fat, improves sleep, heals injuries, or safely improves performance in healthy adults.
What is Mod GRF 1-29 used for?
Mod GRF 1-29 is commonly discussed for growth hormone stimulation, anti-aging, fat loss, muscle gain, recovery, sleep, body composition, and peptide stacking with GHRPs. These uses differ sharply in evidence quality.
| Use | Evidence level | What is known | What is not known | |---|---|---| | Growth hormone stimulation | Mechanistically plausible and supported by related GHRH analog research | GHRH analogs can stimulate GH release through the pituitary. | Mod GRF 1-29 itself lacks strong modern human clinical outcome evidence. | | Anti-aging | Unsupported | Common clinic and online claim. | No strong evidence proves anti-aging or longevity benefits. | | Fat loss/body composition | Weak / extrapolated | GH biology may influence body composition. | Not proven as a safe or effective fat-loss treatment in healthy adults. | | Muscle growth/recovery | Weak / extrapolated | Often marketed to athletes and bodybuilders. | Not proven for muscle growth or recovery, and prohibited in sport. | | Sleep improvement | Weak | GH secretion and sleep biology overlap. | Human evidence does not establish Mod GRF 1-29 as a sleep treatment. | | GH deficiency | Not established | GHRH analogs have endocrine research history. | Mod GRF 1-29 is not FDA-approved for GH deficiency. | | Stacking with ipamorelin or GHRP-2 | Mostly marketing and research extrapolation | GHRH analogs and GHRPs can act through different receptors. | Safety, dosing, long-term effects, and clinical outcomes are not established. | | Online Mod GRF 1-29 products | High uncertainty | Often sold as research-use peptide products. | Quality, sterility, identity, concentration, and safety may be unknown. |
What does the research show?
Human and preclinical evidence for GHRH analogs
The strongest evidence supports a narrow biological claim:
GHRH analogs can stimulate growth hormone release.
A PubMed-indexed study on hGRF 1-29 albumin bioconjugates identified CJC-1295 as a stable and active hGRF 1-29 analog with extended plasma half-life. That research supports the pharmacology of modified GHRH analogs.
A PubMed-indexed paper on testing with GRF 1-29 showed that GRF 1-29 can be used as a growth hormone-releasing factor in endocrine testing contexts.
The practical interpretation:
The GHRH analog concept is real. The weak point is not mechanism. The weak point is consumer claims about anti-aging, muscle growth, fat loss, sleep, and recovery.
Difference between GRF 1-29, Mod GRF 1-29, and CJC-1295 DAC
This is where many peptide websites confuse people.
| Compound | What it is | Practical distinction |
|---|---|---|
| GRF 1-29 / Sermorelin | Unmodified 29-amino-acid active GHRH fragment | Historically FDA-approved as Geref, now discontinued. Short acting. |
| Mod GRF 1-29 | Modified 29-amino-acid GHRH analog | More stable than GRF 1-29, often called CJC-1295 without DAC. |
| CJC-1295 DAC | Modified GHRH analog with drug-affinity-complex | Designed for much longer albumin-binding activity. |
| CJC-1295 without DAC | Common online term for Mod GRF 1-29 | Not the same as CJC-1295 DAC. |
The FDA PCAC material distinguishes CJC-1295 with DAC from CJC-1295 synthesized without DAC. The DAC version includes a maleimidopropionamide-lysine unit designed for drug-affinity-complex behavior.
The practical interpretation:
If a vendor says “CJC-1295,” you need to know whether they mean with DAC or without DAC. Those are not the same product.
Evidence limitations
Most Mod GRF 1-29 claims online are extrapolated from growth hormone biology.
The common online logic is:
- Mod GRF 1-29 stimulates GH release.
- GH affects metabolism, recovery, and body composition.
- Therefore Mod GRF 1-29 should improve fat loss, muscle growth, sleep, recovery, and anti-aging.
That logic is too weak.
The practical interpretation:
Mod GRF 1-29 is biologically plausible as a GH-releasing peptide, but most consumer claims are not supported by strong human clinical-outcome evidence.
Evidence summary
| Claim | Evidence verdict | Explanation |
|---|---|---|
| “Mod GRF 1-29 is a GHRH analog.” | Supported | It is a modified analog of the active 1-29 fragment of GHRH. |
| “Mod GRF 1-29 is CJC-1295 without DAC.” | Common usage / supported by FDA category language | FDA material identifies a CJC-1295 synthesized without DAC category, commonly discussed online as Mod GRF 1-29. |
| “Mod GRF 1-29 stimulates growth hormone release.” | Mechanistically supported | GHRH analogs stimulate GH release through the GHRH receptor. |
| “Mod GRF 1-29 is FDA-approved.” | False | Mod GRF 1-29 is not FDA-approved. |
| “Mod GRF 1-29 is the same as sermorelin.” | False | Sermorelin is unmodified GRF 1-29. Mod GRF 1-29 contains amino-acid substitutions. |
| “Mod GRF 1-29 is the same as CJC-1295 DAC.” | False | CJC-1295 DAC has a drug-affinity-complex modification; Mod GRF 1-29 does not. |
| “Mod GRF 1-29 builds muscle.” | Weak / extrapolated | Often inferred from GH biology, not proven by strong clinical outcome trials. |
| “Mod GRF 1-29 burns fat.” | Weak / extrapolated | Body-composition claims are not supported by strong approval-level evidence. |
| “Mod GRF 1-29 reverses aging.” | Unsupported | Anti-aging and longevity claims are not established. |
| “Mod GRF 1-29 is allowed for athletes.” | False | GHRH analogs and GH-releasing factors are prohibited in sport. |
| “Research-use Mod GRF 1-29 is clinically proven.” | False | Research-use products are not FDA-approved consumer therapeutic products. |
Is Mod GRF 1-29 FDA-approved?
No. Mod GRF 1-29 is not FDA-approved.
There is no FDA-approved Mod GRF 1-29 product for growth hormone deficiency, anti-aging, fat loss, bodybuilding, sleep, recovery, or body recomposition.
Sermorelin, the unmodified GRF 1-29 peptide, has historical FDA approval under the product Geref, but that product is discontinued. That does not make Mod GRF 1-29 approved.
The key distinction:
Mod GRF 1-29 is an unapproved modified GHRH analog, not an FDA-approved prescription medication.
Is Mod GRF 1-29 legal?
Mod GRF 1-29’s legal status depends on product type, intended use, jurisdiction, and how it is sold.
The practical answer is simple:
Mod GRF 1-29 is not an FDA-approved drug, and online availability does not mean it is legally marketed for human therapeutic use.
Some sellers market Mod GRF 1-29 as a research peptide. That does not make it safe, approved, legal, or appropriate for consumer use.
The blunt version:
Buying “research use only” Mod GRF 1-29 online is not the same as receiving an FDA-approved prescription medication from a legitimate pharmacy.
Is Mod GRF 1-29 banned in sports?
Yes. Mod GRF 1-29 should be treated as prohibited in sport.
The WADA Prohibited List prohibits growth hormone-releasing factors, including GHRH and its analogues. Mod GRF 1-29 is a GHRH analog.
For athletes, the answer is simple:
Do not use Mod GRF 1-29 if you are subject to anti-doping rules.
Safety and side effects
Mod GRF 1-29 has real biological activity. It should not be treated like a harmless supplement.
Possible or theoretical concerns include:
- Injection-site reactions
- Headache
- Flushing
- Dizziness
- Nausea
- Water retention
- Tingling or numbness
- Changes in GH and IGF-1 signaling
- Possible glucose or insulin-sensitivity effects
- Possible endocrine-axis disruption
- Unknown long-term safety
- Product-quality and sterility risks from online sources
- Mislabeling or incorrect concentration
- Anti-doping consequences for athletes
The bigger issue is not just side effects. It is uncertainty.
Because Mod GRF 1-29 is not FDA-approved, there is no approved label, dosing protocol, long-term safety database, or standardized quality framework for consumer use.
A serious evaluation of Mod GRF 1-29 should separate controlled peptide research from online peptide-market claims.
Mod GRF 1-29 vs similar peptides
| Compound | Category | Main difference |
|---|---|---|
| Mod GRF 1-29 | Modified GHRH analog | Modified version of GRF 1-29, often called CJC-1295 without DAC. |
| Sermorelin | GHRH analog | Unmodified GRF 1-29; historically FDA-approved as Geref, now discontinued. |
| CJC-1295 DAC | Long-acting GHRH analog | Includes DAC modification for longer albumin-binding activity. |
| CJC-1295 without DAC | Common online term | Usually refers to Mod GRF 1-29. |
| Tesamorelin | GHRH analog | FDA-approved for excess abdominal fat in adults with HIV and lipodystrophy. |
| Ipamorelin | GH secretagogue | Works through ghrelin/GHSR signaling, not GHRH receptor signaling. |
| GHRP-2 | GH secretagogue | Ghrelin receptor agonist, not a GHRH analog. |
| GHRP-6 | GH secretagogue | Ghrelin receptor agonist often associated with appetite effects. |
| Human growth hormone | Recombinant hormone | Supplies GH directly rather than stimulating endogenous release. |
The key distinction:
Mod GRF 1-29 belongs in the GHRH analog category. It is not a GH secretagogue, GLP-1 drug, IGF-1 analog, tissue-repair peptide, or FDA-approved anti-aging medication.
Why is Mod GRF 1-29 sold as “research use only”?
Some online sellers use “research use only” language to sell Mod GRF 1-29 outside normal prescription-drug channels.
That label is not a trust signal.
A serious reader should understand this distinction:
| Product type | What it means |
|---|---|
| Laboratory Mod GRF 1-29 | Research peptide used in controlled experimental settings. |
| FDA-approved Mod GRF 1-29 | Does not currently exist. |
| Sermorelin / GRF 1-29 | Related unmodified GHRH fragment with historical FDA approval, now discontinued. |
| CJC-1295 DAC | Different long-acting DAC-containing GHRH analog. |
| Research-use Mod GRF 1-29 | Not an FDA-approved consumer therapeutic product. |
| Online peptide Mod GRF 1-29 | Higher risk for identity, purity, sterility, dosing, and safety problems. |
How to evaluate Mod GRF 1-29 claims online
| Claim | What to verify |
|---|---|
| “FDA-approved Mod GRF 1-29” | False. Mod GRF 1-29 is not FDA-approved. |
| “Same as sermorelin” | False. Sermorelin is unmodified GRF 1-29. Mod GRF 1-29 is modified. |
| “Same as CJC-1295 DAC” | False. Mod GRF 1-29 does not contain DAC. |
| “CJC-1295 without DAC” | Usually means Mod GRF 1-29, but vendors may use naming inconsistently. |
| “Boosts HGH naturally” | It may stimulate GH release, but that does not prove broad clinical benefit. |
| “Builds muscle and burns fat” | Look for controlled human outcome trials, not just GH biomarker logic. |
| “Anti-aging peptide” | Unsupported by strong clinical evidence. |
| “Improves sleep” | Check for controlled human trials, not anecdotes. |
| “No side effects” | Unsupported. It is hormone-active and long-term safety is not established. |
| “Research use only” | This does not mean safe, legal, approved, or appropriate for human use. |
| “Safe for athletes” | False. GHRH analogs and GH-releasing factors are prohibited in sport. |
| “Third-party tested” | Ask for batch-specific HPLC, LC-MS, identity, purity, sterility, endotoxin, and stability data. |
Bottom line
Mod GRF 1-29 is a modified 29-amino-acid GHRH analog often described as CJC-1295 without DAC. It is designed to stimulate pituitary growth hormone release through the GHRH receptor and is more stable than unmodified GRF 1-29.
The most defensible conclusion is:
Mod GRF 1-29 is a real hormone-active research peptide, not a proven anti-aging or bodybuilding drug. It is not FDA-approved, lacks strong human clinical-outcome evidence for fat loss, muscle growth, sleep, recovery, or longevity, and is prohibited in sport as a GH-releasing factor or GHRH analog.
FAQ
What is Mod GRF 1-29?
Mod GRF 1-29 is a modified analog of growth hormone-releasing hormone based on the 29-amino-acid active fragment of GHRH.
What does Mod GRF 1-29 do?
Mod GRF 1-29 stimulates growth hormone release by activating the GHRH receptor on pituitary cells. This does not prove broad anti-aging, fat-loss, muscle-building, sleep, or recovery benefits.
Is Mod GRF 1-29 FDA-approved?
No. Mod GRF 1-29 is not FDA-approved for growth hormone deficiency, anti-aging, fat loss, bodybuilding, sleep, recovery, or any other therapeutic use.
Is Mod GRF 1-29 the same as sermorelin?
No. Sermorelin is unmodified GRF 1-29. Mod GRF 1-29 is a modified version with amino-acid substitutions designed to improve stability.
Is Mod GRF 1-29 the same as CJC-1295 without DAC?
In common peptide-market usage, yes, Mod GRF 1-29 is often described as CJC-1295 without DAC. However, naming can be inconsistent across vendors, so the exact sequence and certificate of analysis matter.
Is Mod GRF 1-29 the same as CJC-1295 DAC?
No. CJC-1295 DAC contains a drug-affinity-complex modification designed for much longer activity. Mod GRF 1-29 does not contain DAC.
Does Mod GRF 1-29 build muscle?
Muscle-building claims are not well established. Mod GRF 1-29 may stimulate GH release, but that does not prove safe or reliable muscle growth in healthy adults.
Does Mod GRF 1-29 burn fat?
Fat-loss claims are mostly extrapolated from growth hormone biology. Mod GRF 1-29 is not FDA-approved as a fat-loss medication.
Does Mod GRF 1-29 improve sleep?
Sleep claims are common online, but strong human clinical evidence is limited.
Is Mod GRF 1-29 safe?
Mod GRF 1-29 does not have enough long-term human safety data to call it safe for wellness use. It is hormone-active, and online products add identity, purity, sterility, concentration, and dosing risks.
Is Mod GRF 1-29 banned in sports?
Yes. Mod GRF 1-29 should be treated as prohibited because WADA prohibits growth hormone-releasing factors, including GHRH and its analogues.
Why do sellers call Mod GRF 1-29 “research use only”?
Sellers often use “research use only” language because Mod GRF 1-29 is not FDA-approved for consumer therapeutic use. The phrase does not make the product safe, legal, approved, or clinically proven.
What is the biggest risk with Mod GRF 1-29?
The biggest risks are using an unapproved hormone-active peptide without medical supervision, relying on unsupported anti-aging or performance claims, buying online products with uncertain identity and sterility, and violating anti-doping rules.
Sources
- FDA: December 4, 2024 Pharmacy Compounding Advisory Committee Material on CJC-1295
- PubMed: Human Growth Hormone-Releasing Factor hGRF 1-29 Albumin Bioconjugates and CJC-1295
- PMC: Chemical Modification of Class II G-Protein Coupled Receptor Ligands
- PubMed: Potent Long-Acting Growth Hormone Releasing Factor Analogues
- PubMed: Super-Active Analogs of Growth Hormone-Releasing Factor 1-29
- PubMed: Testing with Growth Hormone-Releasing Factor GRF 1-29
- PubMed: Growth Hormone-Releasing Factor Analogue hGRF 1-29 NH2 Pharmacokinetics
- PubMed: Interactions of GRF 1-29 NH2 with Plasma Proteins and Liposomes
- WADA: Prohibited List
- USADA: WADA Prohibited List Guidance
Frequently asked questions
What is Mod GRF 1-29?
Mod GRF 1-29 is a modified analog of growth hormone-releasing hormone based on the 29-amino-acid active fragment of GHRH.
Is Mod GRF 1-29 FDA-approved?
No. Mod GRF 1-29 is not FDA-approved for growth hormone deficiency, anti-aging, fat loss, bodybuilding, sleep, recovery, or any other therapeutic use.
Is Mod GRF 1-29 the same as sermorelin?
No. Sermorelin is unmodified GRF 1-29. Mod GRF 1-29 is a modified version with amino-acid substitutions designed to improve stability.
Is Mod GRF 1-29 the same as CJC-1295 without DAC?
In common peptide-market usage, yes, Mod GRF 1-29 is often described as CJC-1295 without DAC. However, naming can be inconsistent across vendors, so the exact sequence and certificate of analysis matter.
Is Mod GRF 1-29 the same as CJC-1295 DAC?
No. CJC-1295 DAC contains a drug-affinity-complex modification designed for much longer activity. Mod GRF 1-29 does not contain DAC.
Does Mod GRF 1-29 build muscle?
Muscle-building claims are not well established. Mod GRF 1-29 may stimulate GH release, but that does not prove safe or reliable muscle growth in healthy adults.
Is Mod GRF 1-29 safe?
Mod GRF 1-29 does not have enough long-term human safety data to call it safe for wellness use. It is hormone-active, and online products add identity, purity, sterility, concentration, and dosing risks.
Is Mod GRF 1-29 banned in sports?
Yes. Mod GRF 1-29 should be treated as prohibited because WADA prohibits growth hormone-releasing factors, including GHRH and its analogues.
Sources
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]WADA: Prohibited List
Anti Doping
- [10]USADA: WADA Prohibited List Guidance
Anti Doping
Last updated May 9, 2026